The current regulatory environment in the U.S. tolerates overly large PBMs that engage in anticompetitive practices to accumulate excessive profits. Without strong competitors, dominant PBMs are free ...

Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to ...

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

Can the new strategy achieve the great shift Reed has called for, or is the process doomed to failure from the start?

Grocery shopping has become a 'horrifying' experience for many due to the cost of living crisis - and we could end up paying ...

The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...

As Chancellor Rachel Reeves pledges to cut down on “wasteful spending” within public services, weight management expert Margaret Miles-Bramwell ...

Ozempic before and after photos show weight loss. Women share what it's like to lose weight with Ozempic and Wegovy, the side ...

The U.S. Advanced Wound Care market has demonstrated strong growth, with its valuation at $3.35 billion in 2019, and projections suggest it will reach $4.97 billion by 2027. This ...

The global market for Peripheral Artery Disease (PAD) treatments has been witnessing significant growth, with the market size valued at $3,524.77 million in 2019. It is projected to escalate to $5,715 ...

Health equity has improved little in the U.S. despite many efforts, according to a panel discussion on Monday.